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Abstract
Background: In recent years there has been an increasing problem with Staphylococcus aureus strains that are
resistant to treatment with existing antibiotics. An important starting point for the development of new
antimicrobial drugs is the identification of "essential" genes that are important for bacterial survival and growth.
Results: We have developed a robust microarray and PCR-based method, Transposon-Mediated Differential
Hybridisation (TMDH), that uses novel bioinformatics to identify transposon inserts in genome-wide libraries.
Following a microarray-based screen, genes lacking transposon inserts are re-tested using a PCR and sequencing-
based approach. We carried out a TMDH analysis of the S. aureus genome using a large random mariner
transposon library of around a million mutants, and identified a total of 351 S. aureus genes important for survival
and growth in culture. A comparison with the essential gene list experimentally derived for Bacillus subtilis
highlighted interesting differences in both pathways and individual genes.
Conclusion: We have determined the first comprehensive list of S. aureus essential genes. This should act as a
useful starting point for the identification of potential targets for novel antimicrobial compounds. The TMDH
methodology we have developed is generic and could be applied to identify essential genes in other bacterial
pathogens.
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Background
There is an urgent need for the development of novel anti-
microbial agents to counter the increasing problem of
multiply resistant strains of Staphylococcus aureus [1]. A
first step in the development of new classes of antibiotic is
the identification of potential targets within the pathogen
genome. Priority targets are genes and gene products that
are important for bacterial survival and growth [2]. Sev-
eral methods of identifying such "essential" genes are
described in a recent volume [3]. The most rigorous
method is the systematic construction of defined knock-
out mutants across the whole genome. This has been
applied to Bacillus subtilis [4], with essential genes defined
as those for which a mutant could not be obtained, in
many cases being verified by conditional-lethal con-
structs. However this process is time-consuming and
expensive.
An alternative is the use of transposon mutagenesis to
generate a library of random mutants. In general, no
transposons will be present within essential genes, since
the presence of an intragenic transposon will disrupt gene
function. The transposon insertion sites can be deter-
mined through the use of a transposon-specific primer to
amplify the DNA flanking the transposon by PCR. If the
library is saturated with a large number of transposon
insertions, then essential genes can be identified by
genetic footprinting [5]. Alternatively, the primer can be
used to sequence the transposon junction directly [6].
However these approaches require a separate PCR and
sequencing reaction for every mutated gene; consequently
a whole genome screen is again time-consuming and
expensive. A higher throughput can be obtained using
microarrays to identify simultaneously the location of
many inserts [7]; we term these "tag-array" approaches.
The regions flanking transposons can be amplified using
PCR and hybridised to an amplicon microarray [8], how-
ever this is labour intensive and in some cases may be
non-reproducible [9]. An alternative is to use a custom
transposon with one or two outward-facing promoters,
from which labelled RNA run-offs are produced [9]. The
use of high-density tiling microarrays can improve resolu-
tion [10], but this is still inferior to sequencing-based
methods. Small genes (less than ~300 bp) are likely to be
problematic since they are only covered by a small
number of probes on the array. Large transposon libraries
may also be problematic since the signal from a particular
probe may be influenced by RNA derived from multiple
transposons inserted within the same region.
In order to overcome the limitations of current tag-array
approaches we have developed a simple method, Trans-
poson-Mediated Differential Hybridisation (TMDH)
[11,12], that combines the advantages of both sequenc-
ing- and array-based approaches to determine the reper-
toire of genes required for the survival and growth of the
target organism. Application of TMDH to an analysis of
the S. aureus genome identified 351 essential genes. Many
of these may represent potential targets for the develop-
ment of new therapeutic approaches to fight this impor-
tant pathogen. A comparison with the essential gene list of
B. subtilis provides insight into the changes in core metab-
olism that have occurred since the divergence of the two
organisms.
Results
Development of the TMDH procedure
The TMDH procedure is outlined in Figure 1. Genomic
DNA from the TMDH mutant library is digested using an
appropriate restriction enzyme and amplified using linker
PCR. Transcription is induced from the transposon T7
Diagrammatic representation of the TMDH process Figure 1
Diagrammatic representation of the TMDH process. 
a) Illustration of the mariner transposon b) A saturated 
genome-wide transposon library is produced. Cells with a 
transposon disrupting an essential gene will not survive. 
Genomic DNA from the library is restriction digested, and 
Cy5-labelled RNA run-offs are produced from the T7 pro-
moters by in vitro transcription. c) The labelled RNA is 
hybridised to a tiling oligonucleotide microarray. Probes that 
are downstream of a transposon give an "on" signal, other 
probes give an "off" signal. Note that some probes within an 
essential gene can give "on" signals, if they can be influenced 
by transposons outside the gene. Such probes are "non-
informative" (see Results and Figure 4). Similarly, probes 
within a non-essential gene may give an "off" signal if they are 
upstream of the first transposon.



	




		

	




 



			



	


	BMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
Page 3 of 18
(page number not for citation purposes)
promoters in the presence of fluorescently-labelled
dNTPs, and DNaseI is used to remove DNA, leaving
labelled RNA run-offs. The labelled RNA is hybridised to
a microarray, and the retrieved data used to screen for the
presence of transposons as detailed below. Following the
screening process, candidate essential genes are further
interrogated for the presence of transposon inserts using
PCR and DNA sequencing.
The restriction digest is critical for the TMDH procedure as
it provides boundaries to limit the extension of the RNA
run-offs, preventing transcripts produced from trans-
posons within non-essential regions from extending into
adjacent essential genes. However, for any particular
restriction enzyme the distribution of restriction sites may
be sub-optimal for some genes, limiting the number of
"informative probes" that can be used to assess gene
essentiality (see below). To minimise this problem two
TMDH experiments were performed, one using the restric-
tion enzyme AluI (AG^CT), the other using RsaI (GT^AC).
Even using two enzymes, some genes were still potentially
problematic, but sufficiently few that an additional
enzyme was not deemed necessary; the affected genes
were investigated using PCR (see below).
For each TMDH experiment, chromosomal DNA from the
library was digested using the appropriate restriction
enzyme, and oligonucleotide linkers were ligated to the
restriction fragments. Linker PCR was performed using a
linker-specific primer and a transposon-specific primer. In
vitro transcription was performed from the T7 promoters,
with direct incorporation of Cy5-UTP. The reaction was
treated with DNaseI and the resultant labelled RNA was
purified and used for hybridisation to the microarray.
Construction of a TMDH transposon library in S. aureus
Full details are presented in the Methods section. Briefly,
a TMDH transposon, with an outward facing T7 pro-
moter, was initially developed for use in E. coli based on
the transposon Tn5 (EZ:Tn R6k ori Kan transposon, Epi-
centre) [12]. The construct was adapted for use in S. aureus
by the addition of mariner mosaic ends (ME) and an eryth-
romycin resistance gene. It was incorporated into a tem-
perature-sensitive (ts) plasmid that contains a
chloramphenicol resistance gene and is stable for replica-
tion in S. aureus at 30°C and below.
A large transposon library of around a million mutants
was generated in S. aureus SH1000, essentially using the
procedure described by Bae et al. [13]. A serial dilution of
the resulting culture was used to determine library size
(~106 mutants) and DNA sequencing and a preliminary
TMDH analysis were used to demonstrate that the trans-
poson had integrated throughout the S. aureus chromo-
some (see Figure 2).
Strain selection
The TMDH method is designed to work for strains for
which sequence information can be obtained. This
includes non-sequenced strains that are related to strains
with a genome sequence. Our experiments were carried
out in the S. aureus strain SH1000. This was derived from
the genome sequenced strain NCTC 8325 (GenBank
accession: CP000253) through phage curing followed by
reconstruction of the rsbU gene [14-16]. The microarray
probes that were relevant to TMDH in strain SH1000, and
their positions relative to the NCTC 8325 genome
sequence, were determined using BLAST (see Methods).
Microarray procedure
A set of 60-mer oligonucleotide probes was designed
based upon the S. aureus MW2 genome sequence (Gen-
Bank accession: BA000033). The probes were spaced
approximately every 100 bases on both strands across the
whole genome, with the exception of repetitive regions.
In-house inkjet printers capable of generating around
22,000 features per slide were used to produce microar-
rays [17]. As the total number of probes to span the
genome exceeded this capacity, each experiment was per-
formed using three separate slides. Following hybridisa-
tion of the labelled RNA and washing, the arrays were
scanned using an Agilent G2500A scanner, and the images
Cumulative distribution of transposons identified in prelimi- nary experiment Figure 2
Cumulative distribution of transposons identified in 
preliminary experiment. Transposons were located using 
either the PCR/sequencing method or an initial microarray-
based screen. From these experiments it was concluded that 
the mariner transposon inserted throughout the S. aureus 
chromosome and hence was suitable for use in TMDH.
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analyzed using the Agilent Feature Extractor software. Full
details of the microarray procedure are available in the
Methods section.
Development of software to determine location of 
transposon insertions
For TMDH the primary interest is in a discrete binary
property,  i.e. the presence or absence of transposons.
Microarray data are continuously variable, so it is neces-
sary to adopt a strategy for scoring transposons as present
or absent. The log2 of the spot intensities measured from
each microarray show a mixed distribution (see Figure
3a). In the absence of any transposons, low signal intensi-
ties with an approximately normal distribution would be
expected ("off" signals). In contrast, "on" signals would
be expected to have higher intensities but follow an irreg-
ular distribution, reflecting the multiple factors that influ-
ence the signal if transposons are present. These include
the number of transposons present, their distance from
probes, and local sequence elements that may affect tran-
scription from the promoter located in the transposon.
To test our hypothesis that the low intensity signals repre-
sent the "off" distribution, we exploited the differences
between the genomes of the S. aureus strains SH1000, in
which the library was constructed, and MW2, the genome
sequenced strain used to design the microarray probes.
Probes designed to hybridise to MW2-specific genomic
islands will not hybridise to any target from the SH1000
genome, so act as negative controls. Plotting the data from
Illustration of the TMDH microarray scoring system (see text) Figure 3
Illustration of the TMDH microarray scoring system (see text). a) Histogram of log2 of the raw microarray signals. b) 
As a), but overlaid with histogram of log2 of the microarray signals for the probes which do not hybridise to the S. aureus 
NCTC 8325 genome sequence, and hence indicate the background signal level in the absence of labelled transcript. c) A nor-
mal curve is fitted empirically to the data to model the distribution of background signals. d) Cut-offs are defined to classify the 
probe signals as reflecting the presence (+1) or absence (-1) of transposons. Probes with an intermediate signal are scored as 
0, and effectively omitted from the analysis.
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these probes demonstrates that the lower region of the full
distribution corresponds to the signal produced in the
absence of any specific hybridisation (Figure 3b). The
presence of a small number of higher signals within the
negative control dataset suggests some non-specific
hybridisation. This issue is addressed in the microarray
analysis method detailed below.
For the analysis of TMDH data we developed a method for
determining cut-off values to distinguish the "on" and
"off" signals. The method is analogous to one commonly
used in the analysis of microarray data derived from com-
parative genome hybridisation [CGH, also referred to as
genomotyping; [18]]. The "off" distribution is modelled
using a normal distribution fit empirically to the microar-
ray data. A low cut-off point is defined at the point where
the number of probes predicted to show that particular
signal by the fitted distribution drops below the observed
number. A high cut-off is defined at the point where the
fitted distribution explains close to 0% of the observed
data at that intensity. Probes that gave a signal above the
high cut-off were assigned a score of +1, since they were
likely to be influenced by the presence of transposons.
Probes with a signal below the lower cut-off were given a
score of -1, as it is likely that their signal represents the
background level without any influence from the RNA
produced from the transposon promoters. Probes with an
intermediate score were assigned a score of 0, since it was
not possible to infer unambiguously the presence or
absence of transposons. This method accounts for
between-array signal variation, since the curve-fitting pro-
cedure is carried out independently for each array. It
should also be noted that no account is taken of within-
array variation. Standard normalisation approaches can-
not be applied due to the high proportion of "on" signals
within the dataset.
In TMDH, a probe that hybridises within an essential gene
may still give an "on" signal if it is downstream of a trans-
poson that has integrated outside the gene, since RNA
run-offs are defined by restriction enzyme sites, and not
gene boundaries. Therefore the position of the restriction
sites is critical. A method was developed to score only
"informative" probes for each restriction fragment (see
Figure 4). Probes were only considered informative if they
could not be influenced by a transposon outside of the
gene. These included probes downstream of an intragenic
restriction site (shown in Figure 4 as vertical black lines).
If no transposon was evident anywhere within a particular
restriction fragment, then all probes from within that frag-
ment were considered informative, since there could be
no interference from outside the gene.
To determine a list of candidate essential genes in an auto-
mated manner, we examined the score of informative
probes overlapping each gene, across all arrays using both
restriction enzymes. A simple sum of the scores was found
to be the most robust indicator of the presence/absence of
transposons. This exploits the presence of multiple probes
per gene to minimize the impact of any aberrant signals
due to non-specific hybridisation or the lack of normali-
sation. Genes with a total score of -4 or lower were auto-
matically classified as essential. This cut-off was chosen
empirically to minimize the number of false positive
genes that were considered unlikely to be essential based
on their annotation or prior experimental evidence, whilst
retaining most known essential genes. However, the cut-
off also results in the omission of genes that had fewer
than 4 informative probes, due to their short length or the
distribution of restriction sites. The R scripts used to
implement the TMDH scoring system are available upon
request.
PCR-based identification of essential genes
Since the automated analysis of microarray data was not
expected to be comprehensive, we devised a complemen-
tary PCR-based footprinting approach to generate a robust
list of essential genes (see Figure 5). A PCR primer was
designed between 50 and 300 bases upstream of the target
Procedure for identifying "informative probes" for the auto- mated scoring system Figure 4
Procedure for identifying "informative probes" for 
the automated scoring system. a) Probes are only 
informative for a gene if they are downstream of an intra-
genic restriction site. Other probes may be influenced by 
transposons located outside the gene, and give an "on" 
microarray signal (red lines) even if the gene is essential. b) 
The exception to this rule is if there are no "on" signals any-
where within a restriction fragment. In that case all the 
probes within the fragment that overlap the gene are inform-
ative, since there are no interfering signals.
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gene. An outward-facing primer was also designed based
on the mariner transposon sequence. These primers can be
used to amplify a range of products, each corresponding
to one of the transposon inserts in the library. The size of
the products can be determined on an agarose gel, and
from each of these the location of the insert can be deter-
mined. If a gene is essential, no transposons should be
found within the boundaries of the gene, so no PCR prod-
ucts should be seen within the corresponding size range.
Most of these genes were investigated further by DNA
sequencing, and the gene was considered non-essential if
any of the PCR products was confirmed to be derived
from an intragenic transposon. An exception to this rule
was made if a single PCR product was identified in the
region corresponding to the C-terminal portion of the
protein where a transposon insertion was considered
unlikely to disrupt functionality. If a PCR product could
not be obtained, the ability of the gene-specific primer to
generate a PCR product was assessed by linker PCR (see
Methods).
Manual inspection of the raw microarray data using an
online genome browser (http://www-
tmdh.vet.cam.ac.uk) allowed us to identify a number of
candidate essential genes (mostly small essential genes
that are not detectable by the automated analysis). These
genes were investigated using the PCR method. To vali-
date the microarray analysis we also performed the PCR
confirmation step on all genes identified as essential by
the automated method, and also on all genes not identi-
fied as essential in S. aureus, but which had an essential
orthologue in B. subtilis [4].
S. aureus Essential Gene List
Following the preliminary microarray screen and auto-
mated analysis, 274 candidate essential S. aureus genes
were identified. These, together with a further 235 candi-
dates chosen as potentially essential by manual inspection
of the microarray data, or because of their presence in the
B. subtilis essential gene list [4], were further investigated
by PCR and sequencing. Following this process, 351 S.
aureus genes were identified that were not disrupted by
transposons and constitute our putative S. aureus essential
gene list. The genes were classified into the same func-
tional categories as used in the B. subtilis study [4], and a
summary of the findings is presented in Table 1. Addi-
tional file 1 contains a full list of the 351 essential genes
in S. aureus, together with a comparison with the essential
gene list from B. subtilis [4] and a number of previously
published S. aureus "essential gene" studies [13,19-21].
The results are also presented in a more compact form in
Additional file 2. The full results of the PCR/sequencing
analysis are available in Additional file 3. Unless other-
wise stated, gene names below are those from the B. subti-
lis  GenBank entry, with the S. aureus gene name in
parentheses if different. Genes that are unnamed and do
not have a B. subtilis orthologue are referred to by the S.
aureus NCTC 8325 systematic nomenclature, with the pre-
fix "SAOUHSC_".
Influence of experimental conditions on the essential gene 
list
Several studies have been carried out to determine the
minimal set of genes that is essential for growth and rep-
lication of a bacterial cell [22-24]. However, any attempt
to determine this experimentally will inevitably be influ-
enced by the conditions under which the experiment is
performed. A gene may be scored as essential in a particu-
lar assay because it is required for survival following expo-
sure to a particular stress inherent in the method, or
because it is involved in the uptake or metabolism of the
particular nutrients provided in the growth media. An
example of this in our method is the requirement for
extended incubation of S. aureus at 44°C to remove tem-
perature-sensitive replicons. Consequently, genes
required for high temperature survival will be scored as
putatively essential. To test this, we examined defined
mutations in mrpF, dlt, tagO, fur and sarA (classified as
PCR footprinting strategy used to confirm or reject putative  essential genes Figure 5
PCR footprinting strategy used to confirm or reject 
putative essential genes. a) Diagrammatic representation 
of the strategy. PCR is performed using a gene specific 
primer 50–300 bases upstream of the start codon, and a 
primer corresponding to the transposon sequence. b) Agar-
ose gel showing sample results. M – size markers, lane 1 – 
SAOUHSC_00862 (non-essential), lane 2 – 
SAOUHSC_01672 (essential). Each band represents a PCR 
product of a different size, corresponding to a transposon 
insertion in a different position. The white boxes represent 
the product size range expected for transposon insertions 
within the gene. For essential genes this region does not con-
tain bands, since cells with insertions in this region are not 
viable.
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Table 1: Tabulation of S. aureus essential genes by category.
Category Number of essential genes in 
S. aureus
Number of S. aureus essential 
genes with an essential 
orthologue in B. subtilis
Number of B. subtilis essential 
genes with no essential 
orthologue in S. aureus
DNA metabolism 27 22 3
DNA replication 16 16 0
DNA packaging and segregation 11 6 3
RNA metabolism 25 14 2
Basic transcription machinery 4 4 0
RNA modification 10 7 2
RNA regulation 11 3 0
Protein synthesis 102 86 7
Ribosomal proteins 49 47 4
tRNA synthetase 22 20 1
tRNA modification 2 2 0
Translation factors 13 10 1
Protein folding 5 2 0
Protein modification 3 0 0
Protein translocation 8 5 1
Cell envelope 66 43 22
Lipids 15 11 0
Phospholipids 4 4 1
Cell wall/amino sugar 3 3 3
Diaminopimelate biosynthesis 0 0 4
Peptidoglycan biosynthesis 17 10 2
Teichoic acid biosynthesis 12 8 0
Cell division 12 7 0
Cell shape 0 0 3
Na/H transporter 0 0 9
Cell envelope – other 3 0 0
Carbon metabolism 20 9 0
Glycolysis 11 9 0
Pentose phosphate 4 0 0
Intermediary metabolism 3 0 0
R e g u l a t i o n 200
Respiratory pathways 11 4 9
Isoprenoid/Mevalonate 
biosynthesis
812
Menaquinone biosynthesis 1 1 7
T h i o r e d o x i n 220
Nucleotides 12 8 2
Purine biosynthesis 3 2 2
Purine metabolism 1 0 0
Purine/Pyrimidine biosynthesis 3 3 0
Pyrimidine biosynthesis 5 3 0
C o f a c t o r s 2 41 32
Acetyl CoA/CoA 5 1 0
F o l a t e 612
NAD biosynthesis 4 4 0
S A M 110
Fe-sulphate cluster 7 6 0
Riboflavin biosynthesis 1 0 0BMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
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essential from the TMDH score) and all were shown to
confer heat sensitivity in S. aureus (data not shown). Fur-
thermore, mutations in clpP and dnaK can cause a growth
defect at high temperatures [25,26].
Transposon insertions may not be tolerated within a par-
ticular gene even if it is not truly "essential", since they
may have a polar effect on the function of a downstream
essential gene within the same operon. Examples of
potential polarity issues include rimM and recU (possibly
polar on trmD and pbp2, respectively). Under our experi-
mental conditions, false positives may also be identified if
transposon mutagenesis results in a reduced growth rate,
since such mutants may be out-competed within the pool.
Conversely, false negatives are possible since it may be
possible to insert a transposon close to the 3' end of some
essential genes without impairing gene function. Inser-
tions close to the 5' end may also be possible if a suitable
alternative initiation codon is available. This can also be
considered an advantage of the technique, since the trans-
poson screen effectively acts as a truncation assay that
gives an indication of the minimal portion of the gene
sequence required for function.
Evaluation of the microarray method as a screen
The microarray procedure alone was not expected to com-
prehensively identify the complete S. aureus essential gene
list, but was applied as a screen to reduce the workload for
the more robust but laborious PCR-based analysis. How-
ever, for some applications an exhaustive essential gene
list may not be necessary, so it is useful to evaluate the effi-
cacy of the microarray screen. The robust S. aureus essen-
tial gene list obtained using PCR footprinting allows the
sensitivity (percentage of essential genes identified as such
in the screen) and specificity (percentage of non-essential
genes correctly identified by the screen) of the microarray
procedure to be evaluated. Figure 6 shows a ROC curve of
sensitivity against false positive rate (1-specificity) for cut-
off values from -1 to -10. The curve suggests that a cut-off
value of -4 would give an optimal balance between false
positives and false negatives in future studies. This gives a
specificity of 80.3%, with a sensitivity of 99.1%.
The use of multiple restriction enzymes for TMDH has
theoretical advantages, but increases the expense of the
method since it involves an additional set of microarrays.
Knowledge of the robust essential gene list allows us to
evaluate our use of two restriction enzymes, by investigat-
ing the data from each microarray screen separately. The
analysis of the individual microarray screens is also
shown in Figure 6. In these analyses, a cut-off value of -3
is optimal. The AluI experiment performed better than the
experiment using RsaI, with specificities of 74.1% and
70.1%, respectively, but both are inferior to the combined
dataset. The choice of whether to use a single or multiple
enzymes for future studies will depend on the application
and available resources.
Discussion
DNA metabolism
The core set of 16 genes involved in DNA replication from
the B. subtilis essential gene list are all scored as essential
in S. aureus using TMDH. Of the 9 essential B. subtilis
genes involved in DNA packaging and segregation, 6 were
essential in S. aureus. The exceptions were smc, ypuG (scpA)
and ypuH (scpB). The products of these three genes form a
complex that is involved in chromosome condensation
Other/unknown 64 14 2
Amino acid transporter 1 0 0
G T P  b i n d i n g 660
O t h e r 431
Unknown 53 5 1
Table 1: Tabulation of S. aureus essential genes by category. (Continued)
ROC curves showing sensitivity against false positive rate (1- specificity) for the TMDH microarray screens using individual  restriction enzymes, and the combined data from both, for  cut-off values from -1 to -10 Figure 6
ROC curves showing sensitivity against false positive 
rate (1-specificity) for the TMDH microarray screens 
using individual restriction enzymes, and the com-
bined data from both, for cut-off values from -1 to -
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and segregation [27]. The reason for their apparent dis-
pensability in S. aureus is unclear.
The essential B. subtilis DNA methylation genes ydiO and
ydiP do not have homologues in S. aureus. Five additional
genes in this category that were not essential in B. subtilis
were identified as putatively essential in S. aureus: recU,
ruvA, ruvB, yrrK and yvcI. These are all associated with
recombination and repair, and could be essential to sur-
vive the experimental procedure, and thus may be an arte-
fact of the particular methodology that has been used to
generate the transposon library.
RNA metabolism
The four components of the basic transcription machinery
(rpoA, rpoB, rpoC and sigA) are all essential in both B. sub-
tilis and S. aureus. There are eight essential genes involved
in RNA modification in B. subtilis: cca, cspR, rnpA, rnc,
trmU, trmD, ykqC and yqjK. All of these are also essential
in S. aureus, with the exception of rnc, which encodes a
ribonuclease, and cspR, which encodes a putative RNA
methylase. The trmU gene is split into two parts in the
NCTC 8325 genome sequence, but this is due to a
frameshift that occurs in a run of five consecutive adenine
residues and most likely represents a sequencing error, or
a consequence of slipped strand mis-pairing; the gene is
intact in all other available S. aureus genome sequences.
Three additional essential RNA modification genes were
identified in S. aureus, rimM, ymfA and thdF. Insertions in
rimM may not be tolerated due to polar effects on the
essential trmD gene. ymfA is a paralogue of ykqC that is
non-essential in B. subtilis, but is evidently more impor-
tant in S. aureus. The ThdF protein (also known as TrmE)
is a tRNA modification GTPase that is conserved across
bacteria and eukaryotes, and is essential in some
Escherichia coli genetic backgrounds [28]. The three essen-
tial  B. subtilis RNA regulation genes, yycF  (vicR),  yycG
(vicK) and nusA that are conserved in S. aureus are all
essential, together with eight additional putative regula-
tors: glnR, sarA, rnr, yvhJ (msrR), lexA, greA, yjbD and fur.
Protein synthesis
There is no direct experimental evidence that the B. subtilis
complement of 52 ribosomal proteins is essential, but
they are considered as such since the ribosome itself is
essential [4]. Most of the ribosomal genes appear essential
in S. aureus. However, the rpmG genes, of which there are
two copies in both genomes, can each be mutated and are
therefore not individually essential in S. aureus. The two S.
aureus copies are more similar to each other than the two
B. subtilis genes, both showing more similarity to B. subtilis
rpmGA than to rpmGB. rpmE is non-essential in B. subtilis,
due to the presence of two paralogous copies [29], but
essential in S. aureus, which possesses only a single copy.
The rplI and rpsT genes are essential in B. subtilis but not in
S. aureus. The reason for this is unclear. rplK is not essen-
tial in B. subtilis but was identified as essential by TMDH,
possibly due to its involvement in the heat shock response
[30]. rpsJ is not listed as essential as it is not annotated in
the NCTC 8325 genome, but an ORF is present that is pre-
dicted to encode a protein identical to RpsJ from other S.
aureus strains. It is likely that this is an oversight in anno-
tation and rpsJ is identified by TMDH as essential in S.
aureus NCTC 8325.
Of 24 tRNA synthetases listed as essential in B. subtilis, 20
are similarly essential in S. aureus. Two others, glyS and
glyQ, which are adjacent in the B. subtilis genome and
encode the α- and β-subunits of a glycyl-tRNA synthetase,
are not conserved at the sequence level between B. subtilis
and S. aureus. However, at the equivalent position within
a syntenic region, S. aureus has an alternative glyS gene
that is essential. This encodes a class-II glycyl-tRNA syn-
thetase, similar to that encoded by Bacillus cereus [31]. The
thrS and thrZ genes of B. subtilis can compensate for the
absence of each other [4], but only one copy (thrS) is
present in S. aureus, and as may be predicted this is essen-
tial. The asnS gene is essential in B. subtilis but not in S.
aureus. yacA, a gene originally classified as essential but of
unknown function in B. subtilis [4], is involved in the
modification of tRNA-Ile [32] and is also essential in S.
aureus
The ten genes identified as essential translation accessory
factors in B. subtilis are all essential in S. aureus. The S.
aureus list includes three additional genes, homologues of
efp, yrvI and smpB. The SmpB protein is associated with
tmRNA-mediated rescue of stalled ribosomes, and is
important for B. subtilis growth at high temperatures [33].
B. subtilis efp mutants are viable but defective in sporula-
tion [34], however this gene is essential for protein syn-
thesis in E. coli [35]. The yrvI (dtd) gene in B. subtilis lacks
a start codon, and cell extracts have not shown any D-Tyr-
tRNATyr deacylase activity [36], suggesting that the gene is
non-functional in B. subtilis. The gene is intact in other
Bacillus genomes, so the inactivation may have occurred
during the adoption of B. subtilis as a laboratory strain.
The gene is conserved across most bacteria and eukaryo-
tes, and has been suggested to counteract the toxicity of D-
tyrosine [37].
The two genes essential for protein folding in B. subtilis,
groES and groEL, are also essential in S. aureus. Three other
protein folding genes, dnaJ, dnaK and grpE, are scored as
essential in S. aureus, however dnaK mutants are tempera-
ture sensitive [26] so may be viable but unable to survive
the procedure for generating the transposon library. A
homologue of the essential B. subtilis post-translational
modification gene map is also essential in S. aureus, how-
ever, it shows more similarity to the non-essential B. sub-BMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
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tilis gene yflG. Deformylation is essential in B. subtilis, but
the genome contains two genes associated with this proc-
ess (def and ykrB), and either can be inactivated singly [4].
In S. aureus only one deformylation gene, ykrB (pdf1) is
present, and it is essential. Five of the six B. subtilis genes
essential for protein translocation are also essential in S.
aureus. The exception is prsA, which encodes a protein
involved in extracellular folding of secreted proteins.
Three additional protein translocation genes, sipT (spsB),
secDF and yqjG, are essential in S. aureus. In B. subtilis, yqjG
has a paralogue, spoIIIJ, that is absent from S. aureus; in B.
subtilis the double knockout is lethal [38]. sipT encodes
one of four closely related type I signal peptidases in B.
subtilis, whereas only two are present in S. aureus (spsA and
spsB). spsB, which is most closely related to B. subtilis sipT,
is essential [39], and has been targeted for the develop-
ment of novel antimicrobial agents [40]. SpsA, however,
lacks residues essential for catalytic activity and is not
essential [39].
Cell Envelope/Cell Wall and Associated Proteins
Sixteen genes involved in the production of the cell mem-
brane are essential in B. subtilis [4]. Of these, only gpsA,
which encodes an NAD-dependent glycerol-3-phosphate
dehydrogenase, is not essential in S. aureus. Mutants in
this gene in other bacteria are auxotrophic for glycerol
[41]. Four additional cell envelope genes are essential in
S. aureus: fabH, fabI, ywpB and yuxO. The first three of these
are non-essential in B. subtilis due to the presence of a sec-
ond gene with an overlapping function, fabHB, fabL and
ycsD, respectively [42,43,4]. The reason for the essential
nature of yuxO, a possible thioesterase [44], is unclear.
Three additional genes that are thought to encode mem-
brane-associated proteins, pbpX (fmtA), yfiX (fmtC) and
ypbE (ebpS), are also essential in S. aureus but not B. subti-
lis. pbpX may be involved in resistance to high tempera-
tures. EbpS in S. aureus is an elastin binding protein [45]
and although a mutant can be isolated it shows a growth
defect [46]. The multi-subunit sodium-hydrogen anti-
porter encoded by the mrp (mnh) operon is essential in B.
subtilis but not in S. aureus, most likely due to the presence
of a paralogous system in the S. aureus genome. A transpo-
son-insertion mutant of mnhD in S. aureus retains halotol-
erance and loses transmembrane potential during
postexponential growth [47], leading to the suggestion
that the mnh operon is involved in electron transport. It is
possible that the two systems have diverged following a
duplication event, but retain the ability to functionally
compensate for one another.
The essential B. subtilis genes involved in amino sugar bio-
synthesis prior to peptidoglycan polymerization are all
also essential in S. aureus, with the exception of yvyH,
which is present as three copies (capG, capP and mnaA) in
the S. aureus genome. Diaminopimelate biosynthesis is
not important in S. aureus as it uses lysine in its peptidog-
lycan. Of the six B. subtilis essential genes involved in the
process, only four (asd, dapA, dapB and ykuQ) are retained
in S. aureus. These are required for lysine biosynthesis [48]
but are not essential. Of the two racemases that convert L-
glutamate and L-alanine into the corresponding D-iso-
mers, racE is essential in S. aureus, but alr is present as two
copies neither of which is individually essential. The other
genes essential for the synthesis of peptidoglycan precur-
sors in B. subtilis (ddl, murAA, murB, murC, murD, murE,
murF,  murG  and  mraY) are all similarly essential in S.
aureus. Three S. aureus genes absent from B. subtilis, femA,
femB and fmtB (femX), are essential in the formation of the
pentaglycine interpeptide bridge, which is characteristic of
S. aureus peptidoglycan [49]. Also essential in S. aureus
but not B. subtilis are  ponA  (pbp2),  yrvJ  (lytH) and
SAOUHSC_02107. The essential genes involved in tei-
choic acid biosynthesis in B. subtilis are all essential in S.
aureus. The genes dltA, B, C and D are also scored as essen-
tial, but this may be because they are part of the sigma X
regulon which is associated with survival at high temper-
atures in B. subtilis [50].
Perhaps unsurprisingly, given the morphological differ-
ences between the two species, the orthologues of the
essential B. subtilis cell shape determining genes, mreC and
rodA, are not essential in S. aureus, and there is no ortho-
logue of the mreB gene. The essential B. subtilis gene ylaN
is involved in the determination of cell shape, with a sim-
ilar phenotype to rodA [51], and is included in this cate-
gory. Like rodA it is not essential in S. aureus. The seven
essential cell division-related genes described for B. subtilis
are all essential in S. aureus, together with five others:
ylmF, ezrA, yyaA, gidA and ypsB. YlmF can complement the
activity of the FtsZ-binding protein FtsA in B. subtilis, to
the extent that overexpression of YlmF complemented the
otherwise lethal ftsA null mutant [52]. These overlapping
roles seem to have diverged in S. aureus, since both genes
are essential. ezrA encodes a negative regulator of FtsZ ring
formation, which can be knocked out in B. subtilis result-
ing in multiple FtsZ rings [53]. The nucleoid occlusion
protein YyaA (also known as Noc) is essential for cell divi-
sion in the absence of the Min system in B. subtilis; the
genes encoding the Min system are not present in the S.
aureus genome. gidA mutants affect cell division in E. coli
cells grown on glucose [54], and GidA may be involved in
tRNA modification [55]. It is also essential in Helicobacter
[56]. YpsB localizes to the cell division site in B. subtilis,
but its role is unclear [57].
Carbon Metabolism and Respiration
The core essential genes involved in glycolysis in B. subtilis
are also essential in S. aureus. Three additional compo-
nents of the glycolysis pathway are essential in S. aureus:
pgi, gap, and pykA. The essentiality of these three genesBMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
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means that all components of the pathway from glucose
to pyruvate are essential in S. aureus, with the exception of
the initial conversion of glucose to glucose-6-phosphate.
The pentose phosphate pathway also appears to be more
important in S. aureus than B. subtilis, with the component
genes rpe (cfxE), zwf, yqiI (gnd) and SAOUHSC_02612 all
scored as essential. A number of genes that play an inter-
mediary or regulatory role in metabolism are also essen-
tial. These are: sucC, which encodes the beta subunit of
succinyl-CoA synthetase, glnA, which encodes glutamine
synthetase, yvcK, which is of unknown function but is
required for growth on Krebs cycle intermediates and car-
bon sources metabolized by the pentose phosphate path-
way [58], the HPr (Ser) kinase/phosphatase gene hprK,
and the phosphotransferase system component ptsH.
None of these is essential in B. subtilis, although glnA is
essential in Salmonella enterica serovar Typhimurium,
Mycobacterium tuberculosis and  Haemophilus influenzae
[59]. Interestingly, glnR, which encodes a repressor of
glnA, is also scored as essential. The genes are within an
operon, so the essentiality of glnR could be due to polar
effects on glnA.
Perhaps the most striking differences between the essen-
tial gene complements of S. aureus and B. subtilis are in the
respiratory pathways. The menaquinone biosynthesis
pathway, which is essential in B. subtilis, seems to be dis-
pensable in S. aureus, with the exception of the final step
catalyzed by the menA gene product. The isoprenoid path-
way is essential in B. subtilis but in S. aureus it is replaced
by the mevalonate pathway, where it is itself essential, as
it is in other Gram positive cocci [60].
Nucleotides and Cofactors
There are 10 essential genes involved in nucleotide bio-
synthesis in the B. subtilis list. Of these 8 are essential in S.
aureus. guaB was described as essential in the B. subtilis
study, but this was a likely consequence of a lack of gua-
nine in the growth medium [4]: it is not required in S.
aureus, but the downstream gene that encodes GMP syn-
thase,  guaA, is essential. hprT, which was a surprising
inclusion in the B. subtilis list, does not play an essential
role in S. aureus. Three other genes, relA, which encodes
GTP pyrophosphokinase, pyrH  (smbA), which encodes
uridylate kinase, and thyA, which encodes thymidilate
synthase, were all essential in S. aureus. relA, which medi-
ates the stringent response, has previously been reported
as being essential for in vitro growth of S. aureus [61].
Of the genes involved in cofactor biosynthesis, those
required for the production of NAD and SAM are essential
in both S. aureus and B. subtilis. The genes required for the
iron-sulphate cluster in B. subtilis are also essential in S.
aureus, with an additional requirement for ferredoxin
encoded by fer, which is not essential in B. subtilis. The
pathways to produce CoA and folate are more divergent.
In B. subtilis, only the last gene in the CoA biosynthesis
pathway was essential, suggesting that the immediate pre-
cursor (dephospho-CoA) could be scavenged from the
medium [4], but that process does not seem to occur in S.
aureus  under our experimental conditions, since three
other genes involved in CoA biosynthesis were essential,
ylbI, yloI and SAOUHSC_02371. These allow the synthesis
of CoA from the precursor pantothenate, which is pre-
sumably obtained from the growth medium. Similarly,
folate is not obtained from the growth medium, so all the
genes required for its synthesis (yciA, folB, folK, folP, folC
and dfrA) are essential. There are two non-homologous
genes in B. subtilis, yciA and mtrA, that encode a type I GTP
cyclohydrolase (FolE) that catalyses the initial stages of
the pathway from GTP to folate [62]. The S. aureus
genome contains an orthologue of only one of these, yciA,
which is essential. The riboflavin biosynthesis gene ribC
was not identified as essential in B. subtilis in Kobayashi et
al. [4], but had been in an earlier study [63], and is essen-
tial in S. aureus.
Genes of unknown function
Sixty-six putatively essential genes without a clear indica-
tion of their role have been identified in S. aureus. Of
these, 14 are also essential in B. subtilis. Six members of
the family of low molecular mass GTP binding proteins,
proposed to have ribosome-associated functions [64], are
indispensible in B. subtilis and we have found them also
to be essential in S. aureus. Two of the genes, yneS and yfnI
have recently been functionally characterised. YneS (sub-
sequently renamed to PlsY) is a glycerol-3-phosphate acyl
transferase required for fatty acid and phospholipid bio-
synthesis and is essential in B. subtilis [65]. YfnI (renamed
to LtaS) is essential for lipoteichoic acid biosynthesis in S.
aureus but not in B. subtilis due to the presence of numer-
ous paralogues [66]. Elucidation of the function of further
unknowns will shed light on important facets of cellular
physiology and form the basis for potential new antibiotic
targets.
Conclusion
To aid in the selection of targets for drug discovery, we
have developed TMDH, a method for the genome-wide
identification of genes essential for survival and growth in
vitro. An advantage of our system over other tag-array
methods is the software developed for analysis of the
microarray data. Use of this automated scoring system
allows unbiased prediction of essential genes from even
large mutant libraries (in this case a million mutants were
used). This method could be applied in isolation to iden-
tify potential targets for drug discovery or, as is the case
here, used as a preliminary screen to reduce dramatically
the workload required for a PCR footprinting and
sequencing follow-on strategy to locate unambiguouslyBMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
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transposon inserts, and hence infer the essential genes.
Our approach incorporates the advantages of tag-array
methods, genome-wide coverage and efficiency, and the
high resolution associated with PCR/sequencing data.
Application of TMDH to the genome of S. aureus allowed
the construction of a list of 351 genes that were not dis-
rupted by transposon insertions. It is expected that most
of these are essential, although some could be included
on the list for other reasons, such as the presence of "cold
spot" regions that are refractory to transposon insertion,
the possibility of transposon inserts exhibiting polar
effects on downstream genes or an inability of some trans-
poson mutants to survive the experimental process. Nev-
ertheless, the list of genes makes biological sense,
corresponds well with the previously published non-com-
prehensive S. aureus essential gene lists [13,19-21] and the
rigorously determined B. subtilis list [4], and should act as
a useful starting point for the identification of potential
targets for novel antimicrobial compounds. The compari-
son with the B. subtilis essential gene list sheds new light
on the biology of both organisms. The major differences
are in the respiratory pathways and genes associated with
cell morphology, both of which are likely to reflect evolu-
tion in different environmental niches. In a number of
cases genes that are essential in one organism are non-
essential in the other due to the presence of multiple par-
alogous copies that can presumably compensate for each
other. This comparative approach can be used to identify
essential processes that are not dependent on a single gene
product, but may still represent potential targets for drug
development.
TMDH is a powerful technology that can be used for the
determination of the essential gene repertoire of a target
organism. Our analysis of the S. aureus genome is the first
such comprehensive study in this organism and highlights
the potential of the approach. The application of TMDH
to a range of pathogens may highlight important targets
for the development of novel antimicrobial therapies.
TMDH also has additional potential applications, notably
for the identification of conditionally essential genes. One
such application has been the use of TMDH to identify
Salmonella enterica serovar Typhimurium genes required
for infection of BALB/c mice [67].
Methods
Construction of transposons for TMDH in Gram positive 
and Gram negative bacteria
A TMDH-compatible transposon was constructed for use
in E. coli based on Tn5. The EZ:Tn R6k ori Kanr transposon
(Epicentre) was used as a PCR template with oligonucle-
otides: 5'-
CAGCTGTCTCTTATACACATCTCCCTATAGTGAGTCGTA
TTACCCATAATACCCATAATAGCTGTTTGCCAgtcgactcta-
gagg-3' and 5'-
CAGCTGTCTCTTATACACATCTCTTCTATAGTGTCACCT
AAATAGGGATAACAGGGTAATGaattcgttaatacagatgt-3'.
These PCR primers introduce a T7 RNA polymerase site
with the homing endonuclease site PI-PspI, and an SP6
RNA polymerase site with the homing endonuclease site
for I-SceI, respectively. PCR was carried out using a Roche
Expand High Fidelity Kit: 96°C for 3 min, then 5 cycles of
96°C for 30 s, 25°C for 90 s and 72°C for 2 min 30 s, then
a further 25 cycles at 96°C for 30 s, 50°C for 90 s and
72°C for 2 min 30 s, with a final extension step of 4 min-
utes followed by cooling to 4°C. The PCR product was
separated by gel electrophoresis, and the band corre-
sponding to the expected size of 2044 bp cut out and puri-
fied using a gel extraction kit (Qiagen). In order to
evaluate the construct, purified transposon DNA was elec-
troporated into 40 μl TransforMax EC100D pir+ electro-
competent  E. coli (Epicentre) using 0.1 cm cuvettes at
200Ω, 25 μF and 20 kV/cm. Following electroporation,
cells were grown in 1 ml SOC medium (Gibco Life Tech-
nologies) for 1 h at 37°C. Cells were then plated out on L-
Agar (Sigma) containing kanamycin at 30 μg/ml (LB-
kan). DNA was purified from a panel of colonies and their
DNA sequence determined on a Beckman CEQ DNA
sequencer (using the manufacturer's recommended con-
ditions) with kan-2-FP-1 (Epicentre) as a DNA sequencing
primer. One of the plasmids (pETBlueHGK5) was selected
for further study.
Construction of a mariner transposon for TMDH analysis 
of S. aureus
The mariner  mutagenesis system uses two temperature-
sensitive plasmids to introduce transposons into a target
strain [13], one bearing the mariner transposon (TS1), the
other the mariner transposase gene (pFA544). The mariner
plasmids were the kind gift of Dr Fredrik Aslund, Karolin-
ska Institute, Stockholm, Sweden.
In order to construct a mariner transposon designed to
function in S. aureus the following oligonucleotides:
5'-TAACAGGTTGGCTGATAAGTCCCCGGTCTCCCTAT-
AGTGAG-3' and 5'-TAACAGGTTGGCTGATAAGTC-
CCCGGTCTCTTCTATAGTGTC-3' were used to introduce
mariner ME ends to the Tn5 template described above. The
resulting fragment was gel purified (Qiagen), ligated into
the EcoRV restriction site of pETBlue-1 (Novagen), trans-
formed into E. coli and its DNA sequence determined.
Clone 5 pETBlueHGK5 was found to contain the expected
DNA sequence and was used in future experiments. An
erythromycin (erm) resistance determinant was amplified
from pIL253 [68], using the primers: 5'-GATATCGAAG-
CAAACTTAAGAGTGT-3' and 5'-GATATCTA-
CAAAAGCGACTCATAGA-3' using standard conditions
and cloned into pCR2.1 (Invitrogen). The erm cassette wasBMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
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excised from this vector following digestion with EcoRV
(NEB) purified and ligated into HincII (NEB) linearised
pETBlueHGK5. Following transformation and DNA prep-
aration (Qiagen) the DNA sequence of the resulting con-
struct was determined on a Beckman CEQ DNA
sequencer, (using the manufacturer's recommended con-
ditions) and one of the clones (pHGK5erm3) was found
to contain the correct sequence. In order to generate a con-
struct that would function in S. aureus, plasmid TS1 was
digested with the restriction endonuclease BamHI (NEB)
and subsequently made blunt-ended by treatment with
Klenow fragment (Gibco). The blunt-end fragment was
purified and ligated with a BglII-SmaI fragment from
pHGK5erm3 comprising the mariner TMDH transposon
cassette that was also treated with Klenow (as above). The
ligation mixture was then transformed into E. coli PIR1
cells (Epicentre). Following transformation, cells were
plated on LB-Kan (30 μg/ml) and incubated overnight at
37°C. DNA-mini-preps (Qiagen) were sequenced on a
Beckman CEQ DNA sequencer using the manufacturer's
recommended conditions, with the sequencing primers:
5'-AAGATACTGCACTATCAACACACTC-3' and 5'-CTAC-
CCTGTGGAACACCTACATCT-3'. One of the plasmids
(pMARGK2b) was found to contain the correct DNA
sequence and was used for further studies. This plasmid
comprises the TMDH transposon cassette, a temperature
sensitive origin of replication for growth in S. aureus (sta-
ble replication at temperatures of 30°C or below), and a
chloramphenicol resistance gene for selection in S. aureus
at 5 μg/ml.
Construction of a S. aureus TMDH library
The plasmid pMARGK2b was introduced into S. aureus
RN4220 by electroporation (0.5 μg pMARGK2b: 2.3 kV
(0.1 cm cuvettes), 25 μF, 100Ω) using a Gene Pulser (Bio-
rad). Following electroporation, cells were plated out
onto Brain Heart Infusion (BHI) agar (Oxoid) containing
chloramphenicol and erythromycin at 5 μg/ml. Following
successful growth in RN4220, pMARGK2b was transferred
to S. aureus SH1000 with the transducing bacteriophage
phi-11 using standard methods [15]. Plasmid pFA544 car-
rying the mariner  transposase gene was subsequently
introduced into S. aureus SH1000 carrying pMARGK2b by
phi-11 transduction. Transductants were propagated on
BHI agar containing chloramphenicol, erythromycin and
tetracycline (all at 5 μg/ml) at 32°C for 48 h. The resulting
colonies were harvested and inoculated into 600 ml of
BHI broth containing chloramphenicol, erythromycin
and tetracycline (all at 5 μg/ml) and incubated overnight
at 30°C. Following growth, bacteria (100 ml) were recov-
ered by centrifugation at 4000 g  for 5 min and resus-
pended in 5 ml BHI broth containing 50% (v/v) glycerol
and stored in 0.5 ml aliquots at -80°C.
In order to generate a S. aureus SH1000 TMDH mutant
library, 0.5 ml of the glycerol stock was inoculated into
100 ml of BHI broth (at room temperature) containing
chloramphenicol, erythromycin and tetracycline (all at 5
μg/ml) and incubated at 37°C until the culture reached an
A600 of 0.4. Bacteria from a 30 ml sample of this culture
were recovered by centrifugation (4000 g for 5 min) and
the pellet was resuspended in 600 ml BHI broth contain-
ing 5 μg/ml erythromycin (pre-warmed to 44°C) and
grown until the culture reached an A600 of 0.4. Bacteria
from 30 ml of this culture were recovered by centrifuga-
tion at 4000 g for 5 min and the pellet resuspended in 600
ml BHI broth containing 5 μg/ml erythromycin at 44°C
overnight. 10-fold dilutions were made of the resulting
primary library (between 10-3 and 10-6) and 100 μl aliq-
uots were plated onto BHI plates containing chloram-
phenicol, tetracycline or erythromycin (all at 5 μg/ml)
and grown at 37°C overnight. The resulting growth pat-
tern demonstrated that the bacteria were sensitive to tetra-
cycline and chloramphenicol whilst maintaining
resistance to erythromycin. This suggested that the mariner
TMDH cassette had successfully transposed into the S.
aureus  SH1000 chromosome and the two temperature-
sensitive replicons had been lost. This method generated
a TMDH library comprising around 106 mutants. In order
to demonstrate that transposon insertion had occurred
throughout the S. aureus genome, chromosomal DNA was
prepared from a number of colonies and the DNA
sequence flanking the transposon insertion site deter-
mined using the primer 5'-TAGCCAGTTTCGTCGT-
TAAATGCCC-3' that binds 310 bases 5' from the end of
the transposon. The site of transposon integration was
also analyzed for a panel of mutants using the TMDH pro-
tocol (see below). DNA sequencing and a preliminary
TMDH analysis demonstrated that the transposon had
integrated throughout the S. aureus chromosome (see Fig-
ure 2).
In vitro transcription (IVT) reactions
In order to evaluate the suitability of the novel mariner
transposon for the TMDH protocol, preliminary in vitro
transcription (IVT) reactions using both SP6 (SP6 MEGAs-
cript kit; Ambion) and T7 (T7 MEGAshortscript kit,
Ambion) were carried out following the manufacturer's
recommended conditions. 10 μg of genomic DNA from a
TMDH library was digested overnight with a target
enzyme and purified on a QIAquick column (Qiagen)
using the gel extraction protocol, eluted in 200 μl of water,
and analyzed by agarose gel electrophoresis to assess the
completeness of digestion. For each reaction, 20 μl
digested DNA (~1 μg), was reduced in volume by vacuum
drying and incorporated into either SP6 or T7 IVT reac-
tions (Ambion) overnight. RNA from IVT reactions was
treated with DNaseI, purified on a MinElute column (Qia-
gen), eluted with 14 μl of water and quantified by meas-BMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
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urement at OD260. Transcription was observed from both
the SP6 and T7 IVT reactions only when the specific RNA
polymerase was included in reactions bearing the cognate
RNA polymerase binding site.
IVT reactions for mariner  SH1000 TMDH experiments
were produced from DNA fragments flanking the sites of
transposon insertion by a Linker PCR (LPCR) strategy.
Template for the LPCR reaction was generated by ligating
annealed oligonucleotide linkers to restriction digested
genomic DNA. LPCR, using a primer pair corresponding
to the transposon and to the linker, permits the specific
amplification of DNA flanking the site of transposon
insertion including the SP6 or T7 promoter sites. Purified
genomic DNA (10 μg) from the TMDH library was
digested separately with either RsaI or AluI (NEB), in 400
μl, overnight at 37°C. Digested DNA was then purified
using a Gel Extraction Kit (Qiagen) and eluted in 50 μl of
water. Restriction digests were analyzed by agarose gel
(0.8%, w/v, in TBE) electrophoresis to check for complete-
ness. 100 μM each of complementary oligonucleotide
pairs (5'-cgactggacctgga-3' and 5'-gataagcagggatcggaacctc-
caggtccagtcg-3') were annealed by heating to 95°C for 3
min followed by cooling to room temperature over a 1 hr
period. The RsaI or AluI linkers were ligated with restric-
tion digested DNA using standard conditions overnight
and were purified using a Gel Extraction Kit (Qiagen). We
found that during the linker ligation step linkers may self-
ligate, giving rise to background signal in subsequent PCR
steps. To reduce this possibility, the DNA samples were re-
digested with the appropriate restriction enzyme (i.e.
linker-ligated RsaI was re-digested with RsaI while linker-
ligated AluI was re-digested with AluI). The DNA was then
re-purified using a Gel Extraction Kit column (Qiagen).
LPCR amplification of the DNA flanking the transposon
insertion site was carried out with HotStarTaq, (Qiagen)
using the primer pairs: 5'-ctaccctgtggaacacctacatct-3' and
5'-gataagcagggatcggaacc-3' (for the SP6 end) and 5'-cttc-
gatgactggcaaacagc-3' and 5'-gataagcagggatcggaacc-3' (for
the T7 end). Control PCR reactions were performed using
PCR primers alone, as well as reactions omitting template.
LPCR conditions were as follows; 95°C for 15 min; 30
cycles of 94°C for 30 s, 55°C for 1 min and 72°C for 2
min; 72°C for 5 min, pause at 4°C. Products from each
template (AluI, RsaI, T7 and SP6 ends) were purified using
the Qiaquick Gel Extraction Kit (Qiagen). Purified DNA
was analyzed on a 0.8% (w/v) agarose gel run in TBE.
Labelling IVT reactions
IVT reactions were carried out using MEGAscript or
MEGAshortscript (Ambion) reagents with direct incorpo-
ration of either Cy5-UTP or Cy3-UTP (Perkin Elmer). For
the T7 promoter, 3.75 μl 10 mM Cy3-UTP was used with
2 μl buffer (10× Ambion stock); 2 μl each of 75 mM ATP,
CTP and GTP, and 1.5 μl of UTP; 1 μl (up to 4.75 μl) of
template (10 ug of digested gDNA) and 2 μl of enzyme.
For the SP6 promoter, 2.5 μl 10 mM Cy5-UTP was used
with 2 μl buffer (10× Ambion stock); 2 μl each of 50 mM
ATP, CTP and GTP; 1.5 μl 50 mM UTP; 1 μl (up to 6 μl)
template and 2 μl enzyme. The reactions were performed
overnight at 37°C in the dark in 20 μl reaction volumes.
Labelled RNA was subsequently treated with DNaseI
(according to the Ambion protocol) and purified using
RNeasy reagents (Qiagen). The concentration of LPCR-
derived labelled RNA was determined using a spectropho-
tometer (1 AU A260 = 40 μg/ml RNA).
Array hybridisations, washing and scanning
Preliminary whole-genome TMDH experiments showed
there was no increase in signal resolution by using both
T7 and SP6 IVT reactions (labelled with Cy3 and Cy5
respectively), consequently only T7 (Cy3) labelling was
used. However, in preliminary experiments to map the
position of a small number of transposons, arrays were
hybridised with both Cy3 (T7) and Cy5 (SP6) labelled
RNA. 100 μl of labelled RNA was added to the hybridisa-
tion solution. This consisted of 46.6 μl 12 × MES, 112.0 μl
5 M NaCl, 62.0 μl formamide, 22.4 μl 0.5 M EDTA (pH
8.0), 56.0 μl 10% Triton-X-100 and 161.0 μl water, giving
a total volume of 560 μl.
A stock solution of 1 l of MES buffer (2-(N-morpholino)
ethanesulphonic acid) was made from 70.4 g 2N-morp-
holenoethene sulphonic acid (MES free acid) and 193.3 g
of MES sodium salt (pH 6.5 – 6.7) and filter sterilized
through a 0.2 μM) filter. RNA for each array-hybridisation
was made up to 50 μl with water, 50 μl of formamide
added and the mix denatured by incubation at 55°C for 5
min. The resulting 100 μl volume was then added to the
remaining components (460 μl) of hybridisation solu-
tion. Hybridisation solutions were added to each microar-
ray in a Hybridisation Chamber (Agilent) and incubated
at 50°C for 18 hr. Post-hybridisation washes of the arrays
were carried out at room temperature using two 40 ml
SSPE (Sigma)-based solutions of 6 × SSPE, 0.005% N-lau-
ryl sarcosine for 5 min, followed by 0.06 × SSPE, 0.18%
PEG-200 for 5 min. Arrays were then blown-dry using dry-
nitrogen and scanned on an Agilent G2500A Scanner. The
raw microarray data have been deposited in ArrayExpress
(accession number E-MEXP-1588).
PCR on genomic DNA from the transposon library
Individual PCR experiments were carried out with a gene-
specific primer corresponding to a region of genomic
DNA 50–300 bp 5' to the ATG start site (see Additional
file 3) in conjunction with a transposon-specific primer.
PCRs were carried out using HotStarTaq polymerase (Qia-
gen) using the manufacturer's recommended conditions
for the initial set-up (95°C for 15 min) followed by 30BMC Genomics 2009, 10:291 http://www.biomedcentral.com/1471-2164/10/291
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cycles of 95°C for 45 sec, 50°C for 45 sec and 72°C for 2
min, with a final extension step of 72°C for 10 min. PCR
was carried out in a 50 μl reaction mix with a final primer
concentration of 0.2 μM. Following PCR, fragments were
cloned using TOPO cloning reagents (Invitrogen), and the
resulting colonies picked. Colony PCRs were performed
on the colonies and PCR products of the appropriate sizes
were sequenced directly. DNA sequencing was carried out
on an ABI 3100 Automated Capillary DNA Sequencer
using the manufacturer's recommended conditions either
using plasmid DNA or on colony-PCR products using
BigDyeTerminator Cycle Sequencing reagents (Applied
Biosystems). Full results are shown in Additional file 3.
Mapping microarray probes to S. aureus NCTC 8325 
genome
To characterize the differences from the MW2 genome
used to design the microarray, the probes were used as
query sequences in a blastn search of the NCTC 8325
genome sequence (accession CP000253). A probe was
considered to match uniquely the NCTC 8325 genome if
the top hit showed >= 80% identity over >= 50% of the
length of the probe, and the second hit did not fulfil both
of those criteria. Uniquely matching probes were used in
the TMDH analysis, with their hybridisation position on
the NCTC 8325 genome determined from the BLAST
result. Differences between the experimental strain
SH1000 and the genome sequenced strain NCTC 8325
were determined by hybridising genomic DNA from
SH1000 against the MW2 TMDH microarray. The probes
were scored using the trinary method from GACK [18],
and only probes that were scored as present were included
in the TMDH analysis.
Linker PCR
For 87 genes the standard protocol failed to generate PCR
product. Typically, this may be due to either problems
with the gene-specific primer (e.g. mis-synthesis or
sequence error), or the lack of transposons within a spe-
cific genomic region suitable for generating a PCR product
(e.g. the transposon-specific primer is too far away from
the gene-specific primer to generate PCR product under
the conditions used). In order to determine whether the
gene-specific primer was able to generate PCR product,
linker-PCR experiments were carried out using a linker
that effectively introduced a PCR primer binding site prox-
imal to the gene-specific primer. Linkers (5'-gataagcag-
ggatcggaacctccaggtccagtcg-3' and 5'-cgactggacctgga-3')
were annealed as described above. Genomic DNA from
the TMDH library was digested with a 4-base pair blunt-
end restriction endonuclease (either AluI (AG↓CT) or RsaI
(GT↓AC)). The restriction enzyme selection was based on
a bioinformatic analysis of the DNA sequence of the target
gene and chosen to be around 500–1000 bp away from
the gene-specific primer-binding site. Blunt-end ligation
of the linker onto either AluI or RsaI fragments resulted in
the production of short fragments of DNA that could only
be amplified optimally with PCR using a gene-specific
primer in combination with the linker-specific primer
(5'gataagcagggatcggaacc-3') using HotStarTaq polymerase
(Qiagen) conditions described above. As the distance of
the gene-specific primer from the selected restriction site
was known, the size of the resulting PCR product could be
used to determine whether or not the gene-specific primer
was functional. Linker-PCR results are included in Addi-
tional file 3.
Comparison with other published essential gene lists
Previous studies have identified many S. aureus genes as
putatively essential [13,19-21]. As these were identified in
a variety of strains, the equivalent proteins encoded by
strain NCTC 8325 were identified by a blastp search, with
an E-value cut-off of 0.001. BLAST results and xBASE
genome alignments [69] were inspected manually to
determine the most likely orthologue if multiple hits were
obtained. The NCTC 8325 homologues of genes from the
B. subtilis essential gene list [4] were determined using the
same method. In the case of the S. aureus list published by
Ji  et al. [20], the published format used an obsolete
nomenclature, and only 138 of their 168 putative essen-
tial genes could be identified. Forsyth et al. [19] did not
publish their essential list in full, only those genes with
homologues in Mycoplasma genitalium were named and it
is this subset of their data that is included here.
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